UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

Molecular cancer therapeutics, 2016-04, Vol.15 (4), p.743-752

2016

Volltextzugriff (PDF)

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology

Oncotarget, 2015-10, Vol.6 (32), p.32602-32609

2015

Volltextzugriff (PDF)

Differences in regulation of Drosophila and vertebrate integrin affinity by talin

Molecular biology of the cell, 2008-08, Vol.19 (8), p.3589-3598

2008

Volltextzugriff (PDF)

Amino Acid Changes in Drosophila αPS2βPS Integrins That Affect Ligand Affinity

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.5050-5057

2006

Volltextzugriff (PDF)

Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1572-1572

2023

Volltextzugriff (PDF)

Abstract P3-10-18: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-10-18

2020

Volltextzugriff (PDF)

The FGFR landscape in cancer: An analysis of 4,869 cases

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11059-11059

2014

Volltextzugriff (PDF)

Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS4-08-PS4-08

2021

Volltextzugriff (PDF)

Veliparib (V) monotherapy after progression on placebo (PL) + carboplatin/paclitaxel (CP) in patients with advanced HER2-negative g BRCA -associated breast cancer: Crossover outcomes and exploratory biomarker analyses in BROCADE3

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1097-1097

2020

Volltextzugriff (PDF)

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoadjuvant I-SPY 2 trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-11-02

2020

Volltextzugriff (PDF)

Genomic landscape of salivary gland tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6056-6056

2015

Volltextzugriff (PDF)

Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.11103-11103

2015

Volltextzugriff (PDF)

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

NPJ breast cancer, 2021-10, Vol.7 (1), p.131-8, Article 131

2021

Volltextzugriff (PDF)

A phase Ib study of abemaciclib with therapies for metastatic breast cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.522-522

2015

Volltextzugriff (PDF)

Amino Acid Changes in Drosophila Î±PS2Î²PS Integrins That Affect Ligand Affinity

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.5050

2006

Volltextzugriff (PDF)

Amino acid changes in Drosophila alphaPS2betaPS integrins that affect ligand affinity

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.5050

2006

Volltextzugriff (PDF)

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The lancet oncology, 2022-01, Vol.23 (1), p.149-160

2022

Volltextzugriff (PDF)

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

JAMA oncology, 2020-05, Vol.6 (5), p.676

2020

Volltextzugriff (PDF)

Using machine learning techniques to develop forecasting algorithms for postoperative complications: protocol for a retrospective study

BMJ open, 2018-04, Vol.8 (4), p.e020124-e020124

2018

Volltextzugriff (PDF)

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

Frontiers in oncology, 2022-02, Vol.11, p.810023-810023

2022

Volltextzugriff (PDF)

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

Journal of clinical oncology, 2020-04, Vol.38 (10), p.1059-1069

2020

Volltextzugriff (PDF)

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

Clinical cancer research, 2021-09, Vol.27 (18), p.4983-4993

2021

Volltextzugriff (PDF)

Study protocol for the Anesthesiology Control Tower-Feedback Alerts to Supplement Treatments (ACTFAST-3) trial: a pilot randomized controlled trial in intraoperative telemedicine

F1000 research, 2018, Vol.7, p.623

2018

Volltextzugriff (PDF)

Genomic landscape of salivary gland tumors

Oncotarget, 2015-09, Vol.6 (28), p.25631-25645

2015

Volltextzugriff (PDF)

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover)

Clinical cancer research, 2021-09, Vol.27 (18), p.4983-4993

2021

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Oncology
(12)
Humans
(11)
Female
(9)
Middle Aged
(6)
Adult
(5)
Mutation
(5)
Breast Neoplasms - Drug Therapy
(4)
High-Throughput Nucleotide Sequencing
(4)
Male
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Breast Neoplasms - Pathology
(3)
Cell Biology
(3)
Clinical Trials
(3)
Neoplasms - Genetics
(3)
Original Investigation
(3)
Phenotype
(3)
Precision Medicine
(3)
Prognosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology

Differences in regulation of Drosophila and vertebrate integrin affinity by talin

Amino Acid Changes in Drosophila αPS2βPS Integrins That Affect Ligand Affinity

Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency

Abstract P3-10-18: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer

The FGFR landscape in cancer: An analysis of 4,869 cases

Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial

Veliparib (V) monotherapy after progression on placebo (PL) + carboplatin/paclitaxel (CP) in patients with advanced HER2-negative g BRCA -associated breast cancer: Crossover outcomes and exploratory biomarker analyses in BROCADE3

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoadjuvant I-SPY 2 trial

Genomic landscape of salivary gland tumors

Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

A phase Ib study of abemaciclib with therapies for metastatic breast cancer

Amino Acid Changes in Drosophila Î±PS2Î²PS Integrins That Affect Ligand Affinity

Amino acid changes in Drosophila alphaPS2betaPS integrins that affect ligand affinity

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

Using machine learning techniques to develop forecasting algorithms for postoperative complications: protocol for a retrospective study

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

Study protocol for the Anesthesiology Control Tower-Feedback Alerts to Supplement Treatments (ACTFAST-3) trial: a pilot randomized controlled trial in intraoperative telemedicine

Genomic landscape of salivary gland tumors

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover)

Suchergebnisse filtern